Serometrix is a Structure Guided Drug Discovery and Optimization company. The company is delivering better lead compounds to pharma collaborators by rapidly identifying, confirming and optimizing relevant regulatory segments of human proteins. The company's novel platform approach dramatically shortens development times and improve yields. The company's in silico discovery platform probe nature in novel ways to:

• Identify relevant protein-protein interaction sites critical to regulating pathways integral to biological conditions of commercial interest
• Emulate these highly evolved human regulatory sequences (7-10 amino acids) in confirmatory in vitro assays
• Optimize these novel hits using structure based optimization techniques

Utilizing this platform, Serometrix harnesses the clinically predictive power inherent within the human system; the only rational approach that promises to immediately and dramatically enhance productivity in drug development.